⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Ovarian Aging and Premature Ovarian Insufficiency Mechanisms
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-10-09 — Decoding the immune regulation of ovarian aging: mechanisms and therapeutic strategies.: cross-connection with inflammaging: Ovarian immune-microenvironment remodeling (resident macrophage/T-cell skew, local SASP) is nominated as a tractable tissue-local inflammaging substrate directly feeding POI pathogenesis, linking the inflammaging page to the POI mechanisms page. (novelty: 3)
- 2026-10-03 — Elamipretide Rejuvenates Oocyte Quality and Restores Female Fertility During Reproductive Aging: cross-connection with mitochondrial-dysfunction: Elamipretide/SS-31 rescue of aged oocytes links the mitochondrial-dysfunction axis to ovarian aging mechanisms, nominating a mito-targeted peptide intervention for reproductive-aging biology. (novelty: 3)
- 2026-09-23 — Physical Activity Delays Ovarian Aging in Mice: cross-connection with menopause-estrogen-decline: Adiponectin receptor activation extending reproductive span in mice links the menopause-driver frame to POI mechanism work by nominating an adipose-derived hormonal lever over ovarian reserve. (novelty: 3)
- 2026-09-15 — Dietary composition and metabolic stress differentially affect the ovarian microenvironment in mice.: cross-connection with ovarian-stromal-fibrosis: Positions stromal microenvironment remodeling as an early metabolic-stress-driven event that precedes the reserve depletion central to POI mechanisms. (novelty: 3)
- 2026-07-20 — Theca cells: active orchestrators of ovarian aging.: cross-connection with theca-cells-ovarian-aging: Theca-cell senescence/SASP is positioned as an actively driving mechanism (not just a bystander to oocyte/granulosa loss) within the broader POI/DOR mechanistic landscape. (novelty: 3)
- 2026-08-05 — Hepatic SIRT6 Deficiency Accelerates Female-Specific Aging Through SULT1E1-Mediated Estrogen Depletion.: cross-connection with sirt6-longevity-progeria: A liver SIRT6→SULT1E1→estrogen axis reframes systemic estrogen loss as partly hepatic-catabolic rather than purely ovarian, complementing granulosa/oocyte-centric models of female reproductive aging. (novelty: 3)
- 2026-08-17 — Ovarian aging and systemic health: Mechanisms and emerging intervention strategies.: 2026 review consolidates the ovarian–systemic aging axis, arguing cellular defects, SASP-driven local inflammaging, and estrogen decline in the pre-menopausally aging ovary propagate to whole-body aging, and surveys ovary-targeted multimodal interventions (senolytics, mitochondrial support, hormonal/regenerative approaches) as female-healthspan levers — synthesis only, no new primary data. [expert-opinion] (novelty: 3)
- 2026-08-28 — Identifying novel druggable targets and repurposable drugs for premature ovarian insufficiency by integrated multiomics and causal inference analysis.: 2026 integrated proteomic Mendelian randomization + colocalization study nominates seven high-confidence causal plasma-protein targets for POI, with EPHA4, FSTL3, and NUCB2 dysregulation validated in cisplatin-injured mouse ovaries and human granulosa cells, plus computational docking (e.g., cycloheximide–EPHA4) generating drug-repurposing leads — causal-inference plus preclinical validation, no human therapeutic readout. [human-observational] (novelty: 3)
Open questions
Related
Contributing findings
Identifying novel druggable targets and repurposable drugs for premature ovarian insufficiency by integrated multiomics and causal inference analysis.
28-aug-2026
novelty 3
per-area 3
strengthens
Ovarian aging and systemic health: Mechanisms and emerging intervention strategies.
17-aug-2026
novelty 3
per-area 3
strengthens